4//SEC Filing
Brzeczko Albert W 4
Accession 0001104659-23-001410
CIK 0000786947other
Filed
Jan 4, 7:00 PM ET
Accepted
Jan 5, 4:08 PM ET
Size
7.7 KB
Accession
0001104659-23-001410
Insider Transaction Report
Form 4
Brzeczko Albert W
VP Technical Affairs
Transactions
- Exercise/Conversion
Common Stock
2023-01-03+34,000→ 446,001 total - Exercise/Conversion
Restricted Stock Unit (2017 Plan)
2023-01-03+34,000→ 40,000 totalExercise: $0.01→ Common Stock (34,000 underlying)
Footnotes (5)
- [F1]Represents exchange of restricted stock units.
- [F2]Par value of $.01 must be paid by Reporting Person upon exchange of Restricted Stock Units for stock.
- [F3]Does not include Restricted Stock Units.
- [F4]Not Applicable.
- [F5]102,000 Restricted Stock Units were granted on December 11, 2018 and were 100% vested on December 11, 2019. Distributions in respect of this vested Restricted Stock Units will be made in three equal installments in each of 2021, 2022, and 2023 or earlier upon a qualifying change of control which also meets certain criteria of Section 409A of the Internal Revenue Code.
Documents
Issuer
ACURA PHARMACEUTICALS, INC
CIK 0000786947
Entity typeother
Related Parties
1- filerCIK 0001455740
Filing Metadata
- Form type
- 4
- Filed
- Jan 4, 7:00 PM ET
- Accepted
- Jan 5, 4:08 PM ET
- Size
- 7.7 KB